DOCSLIB.ORG

1 Online Only Supplementary Material

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
1 Online Only Supplementary Material Online Only Supplementary Material iNeo Group Information: Contributing units of the International Network for Evaluating Outcomes (iNeo) of Neonates Supplementary Tables: Supplementary Table 1. Adjusted RR (99.9% CI) comparing ROP treatment in survivors between pairs of countries without adjustment for antenatal steroids and cesarean section delivery Supplementary Table 2. Adjusted RR (99.9% CI) comparing Death or ROP treatment between pairs of countries for infants with a GA 240-276 weeks Supplementary Table 3. ROP treatment by year in individual participating networks for infants between A) 24-25 weeks GA and B) 26-27 weeks GA Supplementary Table 4. Comparison of the ROP classification system used in Japan with International classification 1 iNeo Contributing Neonatal Units: ANZNN (Australian and New Zealand Neonatal Network): Australia: Nadia Badawi, MBChB, The Children's Hospital at Westmead, Sydney, New South Wales; Peter Marshall, MBChB, Flinders Medical Centre, Adelaide, South Australia; Paul Craven, MBChB, John Hunter Hospital, New Castle, New South Wales; Karen Simmer, MBChB, King Edward Memorial Hospital and Princess Margaret Hospital, Perth, Western Australia; Jacqueline Stack, MBChB, Liverpool Hospital, Liverpool, New South Wales; Dan Casalaz, MBChB, Mercy Hospital for Women, Melbourne, Victoria; Elizabeth Carse, MBChB, Monash Medical Centre, Melbourne, Victoria; Lucy Cooke, MBChB, Mater Mothers' Hospital, Brisbane Queensland; Vijay Shingde, MBChB, Nepean Hospital, Sydney, New South Wales; David Cartwright, MBChB, Royal Brisbane & Women's Hospital, Brisbane, Queensland; Rod Hunt, MBChB, The Royal Children's Hospital, Melbourne, Victoria; Charles Kilburn, MBChB, Royal Darwin Hospital, Darwin, Northern Territory; Peter Dargaville, MBChB, Royal Hobart Hospital, Hobart, Tasmania; Kei Lui, MBBS, Royal Hospital for Women, Sydney, New South Wales; Mary Paradisis, MBChB, Royal North Shore Hospital, Sydney, New South Wales; Ingrid Rieger, MBChB, Royal Prince Alfred Hospital, Sydney, New South Wales; Carl Kuschel, MBChB, The Royal Women’s Hospital, Melbourne, Victoria; Andrew Numa, MBChB, Sydney Children's Hospital, Sydney, New South Wales; Hazel Carlisle, MBChB, The Canberra Hospital, Canberra, Australian Capital Territory; Guan Koh, MBChB, The Townsville Hospital, Townsville, Queensland; Chad Andersen, MBChB, Women's and Children's Hospital, Adelaide, South Australia; Melissa Luig, MBChB, Westmead Hospital, Sydney, New South Wales. New Zealand: Nicola Austin, MBChB, Christchurch Women's Hospital, Christchurch, Canterbury; Roland Broadbent, MBChB, Dunedin Hospital, Dunedin, Otago; Lindsay Mildenhall, MBChB, Middlemore Hospital, Auckland City, Auckland; Malcolm Battin, MBChB, Auckland City Hospital, Auckland City, Auckland; David Bourchier, MBChB, Waikato Hospital, Hamilton, Waikato; Vaughan Richardson, MBChB, Wellington Women's Hospital, Wellington City, Wellington. CNN (Canadian Neonatal Network): Prakesh S Shah, MD, MSc (Director, Canadian Neonatal Network and site investigator), Mount Sinai Hospital, Toronto, Ontario; Adele Harrison, MD, MBChB, Victoria General Hospital, Victoria, British Columbia; Anne Synnes, MDCM, MHSC, and Joseph Ting, MD, B.C. Women’s Hospital and Health Centre, Vancouver, British Columbia; Zenon Cieslak, MD, Royal Columbian Hospital, New Westminster, British Columbia; Rebecca Sherlock, MD, Surrey Memorial Hospital, Surrey, British Columbia; Wendy Yee, MD, Foothills Medical Centre, Calgary, Alberta; Khalid Aziz, MBBS, MA, MEd, and Jennifer Toye, MD, Royal Alexandra Hospital, Edmonton, Alberta; Carlos Fajardo, MD, Alberta Children’s Hospital, Calgary, Alberta; Zarin Kalapesi, MD, Regina General Hospital, Regina, Saskatchewan; Koravangattu Sankaran, MD, MBBS, and Sibasis Daspal, MD, Royal University Hospital, Saskatoon, Saskatchewan; Mary Seshia, MBChB, Winnipeg Health Sciences Centre, Winnipeg, Manitoba; Ruben Alvaro, MD, St. Boniface General Hospital, Winnipeg, Manitoba; Sandesh Shivananda, MBBS, MD, DM, Hamilton Health Sciences Centre, Hamilton, Ontario; Orlando Da Silva, MD, MSc, London Health Sciences Centre, London, Ontario; Chuks Nwaesei, MD, Windsor Regional Hospital, Windsor, Ontario; Kyong-Soon Lee, MD, MSc, Hospital for Sick Children, Toronto, Ontario; Michael Dunn, MD, Sunnybrook Health Sciences Centre, Toronto, Ontario; Brigitte Lemyre, MD, Children’s Hospital of Eastern Ontario and Ottawa General Hospital, Ottawa, Ontario; Kimberly Dow, MD, Kingston General Hospital, Kingston, Ontario; Ermelinda Pelausa, MD, Jewish General Hospital, Montréal, Québec; Keith Barrington, MBChB, Hôpital Sainte- Justine, Montréal, Québec; Christine Drolet, MD, and Bruno Piedboeuf, MD, Centre Hospitalier Universitaire de Québec, Sainte Foy Québec; Martine Claveau, and Daniel Faucher, MD, McGill University Health Centre, Montréal, Québec; Valerie Bertelle, MD, and Edith Masse, MD, Centre Hospitalier Universitaire de Sherbrooke, Sherbrooke, Québec; Roderick Canning, MD, Moncton Hospital, Moncton, New Brunswick; Hala Makary, MD, Dr. Everett Chalmers Hospital, Fredericton, New Brunswick; Cecil Ojah, MBBS, and Luis Monterrosa, MD, Saint John Regional Hospital, Saint John, New Brunswick; Akhil Deshpandey, MBBS, MRCPI, Janeway Children’s Health and Rehabilitation Centre, St. John’s, Newfoundland; Jehier Afifi, MB BCh, MSc, IWK Health Centre, Halifax, Nova Scotia; Andrzej 2 Kajetanowicz, MD, Cape Breton Regional Hospital, Sydney, Nova Scotia; Shoo K Lee, MBBS, PhD (Chairman, Canadian Neonatal Network), Mount Sinai Hospital, Toronto, Ontario. INN (Israel Neonatal Network): Eli Heymann, MD, Assaf Harofeh Medical Center, Tzrifin; Shmuel Zangen, MD, Barzilai Medical Center, Ashkelon; Tatyana Smolkin, MD, Baruch Padeh Medical Center, Poriya; Francis Mimouni, MD, Bikur Cholim Hospital, Jerusalem; David Bader, MD, Bnai Zion Medical Center, Haifa; Avi Rothschild, MD, Carmel Medical Center, Haifa; Zipora Strauss, Chaim Sheba Medical Center, Ramat Gan; Clari Felszer, MD, Emek Medical Center, Afula; Jamalia Jeryes, MD, French Saint Vincent de Paul Hospital, Nazareth; Smadar Even Tov-Friedman, MD, Hadassah University Hospital-Ein Karem, Jerusalem; Benjamin Bar- Oz, MD, Hadassah University Hospital-Har Hazofim, Jerusalem; Michael Feldman, MD, Hillel Yaffe Medical Center, Hadera; Nizar Saad, MD, Holy Family (Italian) Hospital, Nazareth; Orna Flidel-Rimon, MD, Kaplan Medical Center, Rehovot; Meir Weisbrod, MD, Laniado Hospital, Netanya; Daniel Lubin, MD, Mayanei Hayeshua Medical Center, Bnei Brak; Ita Litmanovitz, MD, Meir Medical Center, Kfar Saba; Amir Kugelman, MD, Rambam Medical Center; Eric Shinwell, MD, Rivka Ziv Medical Center, Safed; Gil Klinger, MD, Schneider Children’s Medical Center of Israel, Rabin Medical Center (Beilinson Campus), Petah Tikva; Yousif Nijim, MD, Scottish (EMMS) Hospital, Nazareth; Francis Mimouni, MD, Shaare- Zedek Medical Center, Jerusalem; Agneta Golan, MD, Soroka Medical Center, Beersheba; Dror Mandel, MD, Sourasky Medical Center, Tel Aviv; Vered Fleisher-Sheffer, MD,Western Galilee Medical Center, Nahariya; David Kohelet, MD, Wolfson Medical Center, Holon; Lev Bakhrakh, MD, Yoseftal Hospital, Eilat. NRNJ (Neonatal Research Network Japan): Satoshi Hattori, MD, Sapporo City Hospital, Sapporo, Hokkaido; Shohei Konishi, MD, Kushiro Red Cross Hospital, Kushiro, Hokkaido); Takasuke Amizuka, MD, Aomori Prefectural Central Hospital, Aomori, Aomori; Takeo Kasai, MD, Iwate Medical University, Morioka, Iwate; Ritsuko Takahasi, MD, Sendai Red Cross Hospital, Sendai, Miyagi; Hirokazu Arai, MD, Akita Red Cross Hospital, Akita, Akita); Maki Sato, MD, Fukushima Medical University, Fukushima, Fukushima; Yayoi Miyazono, MD, Tsukuba University, Tsukuba, Ibaraki; Junichi Shimizu, MD, Tsuchiura Kyodo Hospital, Tsuchiura, Ibaraki; Hiroshi Suzumura, MD, Dokkyo Medical University, Shimotsuga, Tochigi; Yumi Kono, MD, Jichi Medical University, Shimotsuke, Tochigi; Takahiro Inoue, MD, Gunma Children’s Medical Center, Shibukawa, Gunma; Hiroshi Miyabayashi, MD, Saitama Children’s Medical Center, Saitama, Saitama; Hisanori Sobajima, Saitama Medical University, Iruma, Saitama; Rika Ishiguro, Kawaguchi Municipal Medical Center, Kawaguchi, Saitama; Hiroyuki Sato, MD, Kameda General Hospital, Chiba, Kamogawa; Satsuki Totsu, MD, Tokyo Women’s Medical University, Shinjuku, Tokyo; Nozomi Ishii, MD, Aiiku Hospital, Minato, Tokyo; Shigeharu Hosono, MD, Nihon University Itabashi Hospital, Itabashi, Tokyo; Mika Shiraishi, MD, Teikyo University, Itabashi, Tokyo; Humihiro Miura, MD, Showa University, Shinagawa, Tokyo; Atsushi Nakao, MD, Japan Red Cross Medical Center, Shibuya, Tokyo; Hitoshi Yoda, MD, Toho University, Ota, Tokyo; Mitsumasa Shimizu, MD, Tokyo Metropolitan Bokuto Hospital, Sumida, Tokyo; Kazuo Seki, MD, Yokohama City University Medical Center, Yokohama, Kanagawa; Yasuhumi Itani, MD, Kanagawa Children’s Medical Center, Yokohama, Kanagawa; Keiji Suzuki, MD, Tokai University, Isehara, Kanagawa; Atsushi Nemoto, MD, Yamanashi Prefectural Central Hospital, Kofu, Yamanashi; Tomohiko Nakamura, MD, Nagano Children’s Hospital, Azumino, Nagano; Masaki Wada, MD, Niigata University, Niigata, Niigata; Yoshihisa Nagayama, MD, Niigata City Hospital, Niigata, Niigata; Osamu Numata, MD, Nagaoka Red Cross Hospital, Nagaoka, Niigata; Takeshi Futatani, MD, Toyama Prefectural Central Hospital, Toyama, Toyama; Yasuhisa Ueno, MD, Ishikawa Prefectural Central Hospital, Kanazawa, Ishikawa; Kazuyuki Iwai, MD, Fukui Prefectural Hospital, Fukui, Fukui; Yoshinori Kono, MD, Gifu Prefectural Medical Center, Gifu, Gifu); Shigeru Ooki, MD, Seirei Hamamatsu
Load more

Recommended publications
  • Name of Recognized Medical Schools (Foreign)
    1 Name of Recognized Medical Schools (Foreign) Expired AUSTRALIA 1 School of Medicine, Faculty of Heath, University of Tasmania, Tasmania, Australia (5 years Program) 9 Jan Main Affiliated Hospitals 2021 1. Royal H obart Hospital 2. Launceston Gen Hospital 3. NWest Region Hospital 2 Melbourne Medical School, University of Melbourne, Victoria, Australia (4 years Program) 1 Mar Main Affiliated Hospitals 2022 1. St. Vincent’s Public Hospital 2. Epworth Hospital Richmond 3. Austin Health Hospital 4. Bendigo Hospital 5. Western Health (Sunshine, Footscray & Williamstown) 6. Royal Melbourne Hospital Affiliated Hospitals 1. Pater MacCallum Cancer Centre 2. Epworth Hospital Freemasons 3. The Royal Women’s Hospital 4. Mercy Hospital for Women 5. The Northern Hospital 6. Goulburn Valley Health 7. Northeast Health 8. Royal Children’s Hospital 3 School of Medicine and Public Health, University of Newcastle, New South Wales, Australia (5 years Program) 3 May Main Affiliated Hospitals 2022 1.Gosford School 2. John Hunter Hospital Affiliated Hospitals 1. Wyong Hospital 2. Calvary Mater Hospital 3. Belmont Hospital 4. Maitland Hospital 5. Manning Base Hospital & University of Newcastle Department of Rural Health 6. Tamworth Hospital 7. Armidale Hospital 4 Faculty of Medicine, Nursing and Health Sciences, Monash University, Australia (4 and 5 years Program) 8 Nov Main Affiliated Hospitals 1. Eastern Health Clinical School: EHCS 5 Hospitals 2022 2. Southern School for Clinical Sciences: SCS 5 Hospitals 3. Central Clinical School จ ำนวน 6 Hospitals 4. School of Rural Health จ ำนวน 7 Hospital 5 Sydney School of Medicine (Sydney Medical School), Faculty of Medicine and Health, University of Sydney, Australia 12 Dec (4 years Program) 2023 2 Main Affiliated Hospitals 1.
    [Show full text]
  • Challenges Faced by Arab Women Who Are Interested in Becoming Physicians Bishara Bisharat* and Abdalla Bowirrat
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Crossref Bisharat and Bowirrat Israel Journal of Health Policy Research (2015) 4:30 DOI 10.1186/s13584-015-0029-4 Israel Journal of Health Policy Research COMMENTARY Open Access Challenges faced by Arab women who are interested in becoming physicians Bishara Bisharat* and Abdalla Bowirrat Abstract Understanding the underlying reasons for the under-representation of Arab women within the health care system in Israel is crucial for creating future strategies for intervention, in order to minimize the gaps in the health care system and thus improve the medical services and health status. Our commentary tries to shed light on the underrepresentation and the marginalization of the Arab women in society in general and in the medical field in specific. Keywords: Arab physicians, Under-representation, Marginalization, Health system, Israel Commentary under-represented in the medical professions relative to Background their numbers in the general population [1]. The article by Keshet and colleagues [6] addresses the Language and culture concordance improve the health underrepresentation and the marginalization of Arab care provided to the patients, patient-practitioner gender women in the medical field. It does so using an intersec- relations have been associated with improved patient’s tionality approach which stresses the role of gender and health [2]. ethnicity as a research paradigm to clarify the complex- Dyads of patients-physicians of the same gender are char- ity of health inequities. acterized by a more encouraging communication style; both The manuscript discusses various underlying causes of verbal (through positive statements and encouraging back the under-representation of Arab women in the health channel responses) and nonverbal (nodding).
    [Show full text]
  • Impact of Chronic Statins Use on the Development of Esophagitis in Patients with Gastroesophageal Reflux Disease
    Hindawi Canadian Journal of Gastroenterology and Hepatology Volume 2019, Article ID 6415757, 7 pages https://doi.org/10.1155/2019/6415757 Research Article Impact of Chronic Statins Use on the Development of Esophagitis in Patients with Gastroesophageal Reflux Disease Tawfik Khoury ,1,2 Amir Mari ,1 Hana Amara,1 Mohamed Jabaren,3 Abdulla Watad,4 Wiliam Nseir,5 Wisam Sbeit,2 and Mahmud Mahamid 1 1 GastroenterologyandEndoscopyUnited,TeNazarethHospital,EMMS,Nazareth,BarIlanUniversity,Tel-Aviv,Israel 2Institute of Gastroenterology and Liver Disease, Galilee Medical Center, Bar Ilan Faculty of Medicine, Safed, Israel 3Cardiology Department., Haemek Medical Center, Afula, Israel 4Department of Medicine ‘B’ Sheba Medical Center, Tel-Hashomer, Israel 5Internal Medicine Department A, Badeh Barouch Medical Center, Poria, Israel Correspondence should be addressed to Tawfk Khoury; [email protected] Received 25 September 2018; Revised 21 December 2018; Accepted 2 January 2019; Published 3 February 2019 Academic Editor: Armand Abergel Copyright © 2019 Tawfk Khoury et al. Tis is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Background and Aims. We aimed to assess whether chronic statins used (> 6 months) were protective of the development of esophagitis in patients with gastroesophageal refux disease. In the presence of esophagitis, complications such as strictures, Barrett's esophagus, and adenocarcinoma were the most common. Statins, lipid lowering drugs with a pleiotropic efect, are recently implicated in various pathologies. Nevertheless, the possible impact of statins in esophagitis development has never been assessed. Methods. We performed a retrospective, cross-sectional, single center study that included 4148 gastroesophageal refux disease patients from 2014 and 2018 at EMMS Nazareth Hospital.
    [Show full text]
  • Spotted Fever Group Rickettsioses in Israel, 2010–2019
    Spotted Fever Group Rickettsioses in Israel, 2010–2019 Regev Cohen, Talya Finn, Frida Babushkin, Yael Paran, Ronen Ben Ami, Alaa Atamna, Sharon Reisfeld, Gabriel Weber, Neta Petersiel, Hiba Zayyad, Eyal Leshem, Miriam Weinberger, Yasmin Maor, Nicola Makhoul, Lior Nesher, Galia Zaide, Dar Klein, Adi Beth-Din, Yafi t Atiya-Nasagi ≈ In a multicenter, nationwide, retrospective study of pa- SFGRs are associated with 20 species of Rickettsia, tients hospitalized with spotted fever group rickettsiosis of which 16 are considered human pathogens (1,2). in Israel during 2010–2019, we identifi ed 42 cases, of Recent introduction of molecular methods provided which 36 were autochthonous. The most prevalent spe- more information about SFGR agents causing human cies was the Rickettsia conorii Israeli tick typhus strain (n disease and enabled their identifi cation, for which = 33, 79%); infection with this species necessitated inten- the clinical signifi cance of some remains lacking (3). sive care for 52% of patients and was associated with a R. conorii complex, the etiologic agent of Mediterra- 30% fatality rate. A history of tick bite was rare, found for nean spotted fever, includes 4 strains: R. conorii Mal- only 5% of patients; eschar was found in 12%; and leuko- ish (cause of Mediterranean spotted fever), R. conorii cytosis was more common than leukopenia. Most (72%) Astrakhan (cause of Astrakhan fever), R. conorii In- patients resided along the Mediterranean shoreline. For 3 dian tick typhus (cause of Indian tick typhus), and R. patients, a new Rickettsia variant was identifi ed and had been acquired in eastern, mountainous parts of Israel.
    [Show full text]
  • Survival in Very Preterm Infants: Kjell Helenius, MD,​A,B​ Gunnar Sjörs, MD,​C Prakesh S
    Survival in Very Preterm Infants: Kjell Helenius, MD, a, b Gunnar Sjörs, MD, c Prakesh S. Shah, MD, Msc, d, e Neena Modi, MD, f Brian Reichman, MBChB, g Naho AnMorisaki, MD,International PhD, h Satoshi Kusuda, MD, i Kei Lui, MD, jComparison Brian A. Darlow, MD, k Dirk Bassler, MD, of MSc, l Stellan Håkansson, MD, c Mark Adams, MSc, l Maximo Vento, MD, PhD, m Franca Rusconi, MD, n Tetsuya Isayama, MD, e Shoo K. Lee, MBBS, 10PhD, d, e Liisa National Lehtonen, MD, a, b on behalf Neonatal of the International Network Networks for Evaluating Outcomes (iNeo) of Neonates OBJECTIVES: abstract To compare survival rates and age at death among very preterm infants in 10 METHODS: national and regional neonatal networks. ’ A cohort study of very preterm infants, born between 24 and 29 weeks gestation and weighing <1500 g, admitted to participating neonatal units between 2007 and 2013 in the International Network for Evaluating Outcomes of Neonates. Survival was compared by using standardized ratios (SRs) comparing survival in each network to the survival RESULTS: estimate of the whole population. Network populations differed with respect to rates of cesarean birth, exposure – to antenatal steroids and birth in nontertiary hospitals. Network SRs for survival were – highest in Japan (SR: 1.10; 99% confidence interval: 1.08 1.13) and lowest in Spain (SR: ’ – 0.88; 99% confidence interval: 0.85 0.90). The overall survival differed from 78% to 93% among networks, the difference being highest at 24 weeks gestation (range 35% 84%). – ’ Survival rates increased and differences between networks diminished with increasing gestational age (GA) (range 92% 98% at 29 weeks gestation); yet, relative differences in survival followed a similar pattern at all GAs.
    [Show full text]
  • Antibiotic Treatment for Invasive Listeriosis and Patient
    Antibiotic treatment for invasive listeriosis and patient outcome: a retrospective cohort study Yaakov Dickstein1, Yonatan Oster2, Orit Shimon3, Lior Nesher4, Dafna Yahav3,5, Yonit Wiener-Well6, Regev Cohen7,8, Ronen Ben-Ami3,9, Miriam Weinberger3,10, Galia Rahav3,11, Yasmin Maor3,12, Michal Chowers3,13, Ran Nir-Paz2, Mical Paul1,8 1 Institute of Infectious Diseases, Rambam Health Care Campus, Haifa, Israel 2 Department of Clinical Microbiology and Infectious Diseases, Hadassah-Hebrew University Medical Center, Jerusalem, Israel 3 Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel 4 Infectious Disease Institute, Soroka Medical Center, Ben-Gurion University of the Negev, Beer Sheba, Israel 5 Infectious Diseases Unit, Rabin Medical Center, Beilinson hospital, Petah-Tikva, Israel 6 Infectious Disease Unit, Shaare Zedek Medical Center, Jerusalem, Israel 7 Infectious Diseases Unit, Sanz Medical Center–Laniado Hospital , Netanya, Israel 8 The Ruth and Bruce Rappaport Faculty of Medicine, Technion, Haifa, Israel 9 Infectious Diseases Unit, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel 10 Infectious Diseases Unit, Assaf Harofeh Medical Center, Zerifin, Israel 11 Infectious Disease Unit, Sheba Medical Center, Ramat Gan, Israel 12 Infectious Disease Unit, Wolfson Medical Center, Holon, Israel 13 Infectious Diseases Unit, Meir Medical Center, Kfar Saba, Israel Cumulative survival by treatment group Background: Current treatment started within 48 hours of culture recommendations for treatment of results and continued for a minimum duration invasive listeriosis suggest ampicillin- of 7 days. Patients who died within 48 hours of based therapy with the addition of an the index culture were excluded. The primary aminoglycoside. However, several outcome was 30-day all-cause mortality.
    [Show full text]
  • Searching the Internet for Psychiatric Disorders Among Arab and Jewish Israelis: Insights from a Comprehensive Infodemiological Survey
    Searching the Internet for psychiatric disorders among Arab and Jewish Israelis: insights from a comprehensive infodemiological survey Mohammad Adawi1, Howard Amital2, Mahmud Mahamid3, Daniela Amital5, Bishara Bisharat3,4, Naim Mahroum2, Kassem Sharif2, Adi Guy6, Amin Adawi3, Hussein Mahagna6, Arsalan Abu Much6, Samaa Watad7, Nicola Luigi Bragazzi8 and Abdulla Watad2 1 Padeh and Ziv Medical Centers, Azrieli Faculty of Medicine, Bar-Ilan University, Zefat, Israel 2 Zabludowicz Center for Autoimmune Diseases, Department of Medicine B, Sheba Medical Center, and Sackler Faculty of Medicine, Tel Aviv University, Ramat Gan, Israel 3 EMMS Nazareth Hospital, Nazareth, Azrieli Faculty of Medicine, Bar-Ilan University, Safed, Israel 4 The Society for Health Promotion of the Arab Community, The Max Stern Yezreel Valley College, Nazareth, Israel 5 Sackler Faculty of Medicine, Tel Aviv University, Ness Ziona-Beer Yaacov Mental Health Center, Beer-Yaacov, Tel Aviv, Israel 6 Department of Medicine B, Sheba Medical Center, and Sackler Faculty of Medicine, Tel Aviv University, Ramat Gan, Israel 7 Department of Statistics and Operations Research, Tel Aviiv University, Tel Aviv, Israel 8 Department of Health Sciences (DISSAL), School of Public Health, University of Genoa, Genoa, Italy ABSTRACT Israel represents a complex and pluralistic society comprising two major ethno- national groups, Israeli Jews and Israeli Arabs, which differ in terms of religious and cultural values as well as social constructs. According to the so-called ``diversification hypothesis'', within the framework of e-health and in the era of new information and communication technologies, seeking online health information could be a channel to increase health literacy, especially among disadvantaged groups. However, little is Submitted 12 December 2017 known concerning digital seeking behavior and, in particular, digital mental health Accepted 25 February 2018 Published 14 March 2018 literacy.
    [Show full text]
  • BMJ Open Is Committed to Open Peer Review. As Part of This Commitment We Make the Peer Review History of Every Article We Publish Publicly Available
    BMJ Open: first published as 10.1136/bmjopen-2020-040210 on 8 February 2021. Downloaded from BMJ Open is committed to open peer review. As part of this commitment we make the peer review history of every article we publish publicly available. When an article is published we post the peer reviewers’ comments and the authors’ responses online. We also post the versions of the paper that were used during peer review. These are the versions that the peer review comments apply to. The versions of the paper that follow are the versions that were submitted during the peer review process. They are not the versions of record or the final published versions. They should not be cited or distributed as the published version of this manuscript. BMJ Open is an open access journal and the full, final, typeset and author-corrected version of record of the manuscript is available on our site with no access controls, subscription charges or pay-per-view fees (http://bmjopen.bmj.com). If you have any questions on BMJ Open’s open peer review process please email [email protected] http://bmjopen.bmj.com/ on September 26, 2021 by guest. Protected copyright. BMJ Open BMJ Open: first published as 10.1136/bmjopen-2020-040210 on 8 February 2021. Downloaded from PipEracillin Tazobactam versus mERoPENem for treatment of bloodstream infections caused by cephalosporin-resistant Enterobacteriaceae - a non-inferiority randomized controlled trial (PeterPen) ForJournal: peerBMJ Open review only Manuscript ID bmjopen-2020-040210 Article Type: Protocol Date Submitted
    [Show full text]
  • The IFSO Global Registry 5Th IFSO Global Registry Report 2019
    The IFSO Global Registry 5th IFSO Global Registry Report 2019 Prepared by Almino Ramos MD MSc PhD FACS FASMBS Lilian Kow BMBS PhD FRACS Wendy Brown MBBS PhD FACS FRACS Richard Welbourn MD FRCS John Dixon PhD FRACGP FRCP Edin Robin Kinsman BSc PhD Peter Walton MA MB BChir MBA FRCP IFSO & Dendrite Clinical Systems The International Federation for the Surgery of Obesity and Metabolic Disorders Fifth IFSO Global Registry Report 2019 Prepared by Almino Ramos MD MSc PhD FACS FASMBS Lilian Kow BMBS PhD FRACS Wendy Brown MBBS PhD FACS FRACS Richard Welbourn MD FRCS John Dixon PhD FRACGP FRCP Edin Robin Kinsman BSc PhD Peter Walton MA MB BChir MBA FRCP IFSO & Dendrite Clinical Systems The International Federation for the Surgery of Obesity and Metabolic Disorders operates the IFSO Global Registry in partnership with Dendrite Clinical Systems Limited. IFSO gratefully acknowledge the assistance of Dendrite Clinical Systems for: • building, maintaining & hosting the web registry • data analysis and • publishing this report Dendrite Clinical Systems Ltd maintains the following United Kingdom and GDPR-compliant Information Governance and Data Security Certificates: • Registration with the UK Government Information Commissioner’s Office (ICO) • NHS Data Security & Protection Toolkit (ODS code 8HJ38) • Cyber Essentials Plus (Registration number QGCE 1448) • G-Cloud 11 (Framework reference RM1557.11) This document is proprietary information that is protected by copyright. All rights reserved. No part of this document may be photocopied, stored in a retrieval system, transmitted in any form or by any means, electronic, mechanical, photocopying, recording or otherwise, without the permission of the publishers and without prior written consent from IFSO and Dendrite Clinical Systems Limited.
    [Show full text]
  • Israeli Pediatric Surgery Association and Pediatric Section of Urology Association ‏Summer Meeting 30.06 - 02.07.2016
    ההסתדרות הרפואית בישראל ediatricהאיגוד הישראלי לכירורגית ילדים– והחוג לאורולוגית ילדים באיגוד rgeryהאורולוגים Suהישראלי ד”ר יחיאל שויד - יו”ר ד”ר עמוס נעמן - יו”ר פרופ’ איגור סוחוטניק- מזכיר ד”ר דרגן קרברושיץ- גזבר ד”ר צבי שטיינר- חבר Israeli Pediatric Surgery Association and Pediatric Section of Urology Association Summer Meeting 30.06 - 02.07.2016 Nahsholim, Sea Side Resort June 30, Thursday 15.00-17:00 Accommodation 17:00-17:30 Registration 17:30-17:45 Opening Remarks: Yechiel Sweed, MD Session 1 Chairmen: Yuval Bar-Yosef; Ran Steinberg 17:45-18:15 Management of Vesicoureteral Reflux: Current Status Prem Puri National Children’s Research Centre, Dublin School of Medicine and Medical Science and Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Dublin, Ireland 18:15-19:00 A Professional Lifetime with the Foregut and the Hindgut: Redo Esophageal and Rectal Surgery Arnold G Coran Emeritus Professor of Surgery Section of Pediatric Surgery C.S. Mott Children’s Hospital and University of Michi- gan Medical School, Ann Arbor, MI, USA Dinner 19.00-20.30 Social Program 21:00 July 1, Friday Session 1 Chairs: Boris Chertin; Amos Vromen 8:30- 9:00 Malignant Testicular Tumors: New Therapeutic Approaches Myriam Weyl Ben Arush The Joan and Sanford Weill Pediatric Hematology Oncology and Bone Marrow Transplantation Division, the Ruth Rappaport Children’s Hospital, Rambam Health Care Campus, Technion Faculty of Medicine, Haifa, Israel 9:00-9:30 Variant Hirschsprung’s Disease Prem Puri National Children’s Research Centre, Dublin School of Medicine and Medical Science and Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Dublin, Ireland 9:30-10:00 Update in Fetal, Neonatal and Pediatric Radiology Liat Ben-Sira Tel Aviv Sourasky Medical Center, Tel Aviv University.
    [Show full text]
  • Guideline for Management at the Extremes of Prematurity
    Thames Valley & Wessex Operational Delivery Networks (Hosted by University Hospital Southampton NHS Foundation Trust) THAMES VALLEY & WESSEX NEONATAL OPERATIONAL DELIVERY NETWORK Guideline for Management at the Extremes of Prematurity Approved by/on: Thames Valley & Wessex Neonatal ODN Governance Group December 2020. Date of publication September 2020 Last Reviewed January 2021 Review date (Max 3 years) January 2024 Natalie Crawford, Patient Safety Felloe, O&G Trainee Lambri Yianni, Neonatal Transformation Fellow, TV&W Neonatal GRID Authors Trainee Tara Selman, UHS Consultant Obstetrician Victoria Puddy Wessex Neonatal ODN Clinical Lead Distribution Thames Valley and Wessex Neonatal Clinical Forum Thames Valley and Wessex Neonatal Network website Thames Valley and Wessex Neonatal Network e-bulletin Related documents References BAPM 2019. Perinatal Management of Extreme Preterm Birth before 27 weeks of gestation. A Framework for Practice. https://hubble-live- assets.s3.amazonaws.com/bapm/attachment/file/182/Extreme_Preterm_28- 11-19_FINAL.pdf Royal College of Obstetricians & Gynaecologists, 2014. Perinatal management of pregnant women at the threshold of infant viability (the obstetric perspective) scientific impact paper no. 41. UK: RCOG. Crowther et al Repeated doses of prenatal corticosteroids for women at risk of preterm birth for improving neonatal health outcomes. Cochrane Database Syst Rev 2015 7: CD003935 McKinlay et al Repeat antenatal glucocorticoids for women at risk of preterm birth: a Cochrane Systematic Review. Am J OG 2012 206 (3): 187- 194 https://www.togetherforshortlives.org.uk/wp- content/uploads/2018/01/ProRes-Core-Care-Pathway.pdf Macfarlane PI, Wood S, Bennett J. Non-viable delivery at 20-23 weeks gestation: observations and signs of life after birth.
    [Show full text]
  • P2463 Antibiotic Treatment for Invasive Listeriosis and Patient
    P2463 Antibiotic treatment for invasive listeriosis and patient outcome: a retrospective cohort study Yaakov Dickstein*1, Yonatan Oster2, Orit Shimon3, Lior Nesher4, Dafna Yahav5,3, Yonit Wiener-Well6, Regev Cohen7,8, Ronen Ben-Ami9,3, Miriam Weinberger10,3, Galia Rahav11,3, Yasmin Maor12,3, Michal Chowers13,3, Ran Nir-Paz2, Mical Paul8,14 1 Rambam Healthcare Campus, Haifa, Israel, 2 Hadassah University Hospital - Ein Kerem, Jerusalem, Israel, 3 Tel Aviv University, Sackler Faculty of Medicine, Ramat Aviv, Israel, 4 Soroka Medical Center, Beersheba, Israel, 5 Rabin Medical Center, Petah Tikva, Israel, 6 Shaare Zedek, Jerusalem, Israel, 7 Laniado Hospital, Netanya, Israel, 8 Technion, The Ruth and Bruce Rappaport Faculty of Medicine, Haifa, Israel, 9 Tel Aviv Sourasky Medical Center , Tel Aviv, Israel, 10 Assaf Harofeh Medical Center, Be’er Ya’akov, Israel, 11 Sheba Medical Center, Ramat Gan, Israel, 12 Wolfson Medical Center, Holon, Israel, 13 Meir Medical Center, Kefar Sava, Israel, 14 Infectious Diseases Unit, Rambam Health Care Campus, Haifa, Israel Background: Current recommendations for treatment of invasive listeriosis suggest ampicillin-based therapy with the addition of an aminoglycoside. However, several reports have suggested higher morbidity and mortality with this regimen as compared with beta-lactam monotherapy. We aimed to evaluate the association between penicillin-aminoglycoside combination therapy and mortality in patients with invasive listeriosis while adjusting for timing of treatment onset. Materials/methods: This is a multicenter retrospective observational study of adult patients with invasive listeriosis (primary bacteremia, central nervous system [CNS] disease and pregnancy-associated listeriosis) in 11 hospitals in Israel between the years 2008-2014. We evaluated the effect of penicillin-based monotherapy compared with early combination therapy with gentamicin, defined as treatment started within 48 hours of culture results and continued for a minimum duration of 7 days.
    [Show full text]